
Significance of Circulating Tumor Cells in Metastatic Triple-Negative Breast Cancer Patients within a Randomized, Phase II Trial: TBCRC 019
Author(s) -
Costanza Paoletti,
Yufeng Li,
Maria C. Muñiz,
Kelley M. Kidwell,
Kimberly Aung,
Dafydd G. Thomas,
Martha E. Brown,
Vandana G. Abramson,
William Irvin,
Nancy U. Lin,
Minetta C. Liu,
Rita Nanda,
Julie R. Nangia,
Anna Maria Storniolo,
Tiffany A. Traina,
Christos Vaklavas,
Catherine Van Poznak,
Antonio C. Wolff,
Andrés Forero-Torres,
Daniel F. Hayes
Publication year - 2015
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/e9ys-9994
Subject(s) - metastatic breast cancer , breast cancer , medicine , oncology , circulating tumor cell , triple negative breast cancer , triple negative , randomized controlled trial , cancer , metastasis